SARS-CoV-2 recombinant protein vaccine (monovalent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 recombinant protein vaccine (monovalent), covering 2024-10-16 to 2024-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older [Phase 3]